NutriBand (NTRB) Cash from Operations (2016 - 2026)
NutriBand's (NTRB) quarterly Cash from Operations came in at 731830.0 in Q1 2026, up 40.95% year-on-year from 519229.26 in Q1 2025, and up 58.24% quarter-over-quarter from 1752487.0 in Q4 2025.
NutriBand (NTRB) Cash from Operations (2016 - 2026) Analysis & Trends
NutriBand has disclosed Cash from Operations across 11 years of filings, most recently posting 731830.0 for Q1 2026.
- Cash from Operations for Q1 2026 came in at 731830.0, up 40.95% year-over-year; the trailing twelve-month figure through Jan 2026 was 5134630.0 (down 10.98% YoY), and the FY2026 annual result was 5134630.0, down 10.98% from the prior year.
- Cash from Operations came in at 731830.0 for Q1 2026 at NutriBand, up from 1752487.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 520443.0 in Q4 2022 to a low of 1752487.0 in Q4 2025.
- The 5-year median for Cash from Operations is 995135.0 (2023), against an average of 1029902.06.
- Peak annual rise in Cash from Operations reached 56.95% in 2022, while the deepest fall reached 1382.25% in 2022.
- NutriBand's Cash from Operations stood at 520443.0 in 2022, then plunged by 104.49% to 1064270.0 in 2023, then advanced by 5.13% to 1009647.0 in 2024, then slumped by 73.57% to 1752487.0 in 2025, then soared by 58.24% to 731830.0 in 2026.
- The last three Cash from Operations figures came in at 731830.0 (Q1 2026), 1752487.0 (Q4 2025), and 1313341.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -2.49 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | NutriBand | 41.91 Mn | 37.33 Mn | 88,941.00 | -731,830.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -731,830.00 |
| Jan 31, 2026 | -731,830.00 |
| Oct 31, 2025 | -1.75 Mn |
| Oct 31, 2025 | -1.75 Mn |
| Jul 31, 2025 | -1.31 Mn |
| Jul 31, 2025 | -1.31 Mn |
| Apr 30, 2025 | -1.34 Mn |
| Apr 30, 2025 | -1.34 Mn |
| Jan 31, 2025 | -1.24 Mn |
| Jan 31, 2025 | -1.24 Mn |
| Oct 31, 2024 | -1.01 Mn |
| Oct 31, 2024 | -1.01 Mn |
| Jul 31, 2024 | -1.54 Mn |
| Jul 31, 2024 | -1.54 Mn |
| Apr 30, 2024 | -833,926.00 |
| Apr 30, 2024 | -833,926.00 |
| Jan 31, 2024 | -718,240.00 |
| Jan 31, 2024 | -718,240.00 |
| Oct 31, 2023 | -1.06 Mn |
| Oct 31, 2023 | -1.06 Mn |